Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · IEX Real-Time Price · USD
1.220
-0.030 (-2.40%)
May 7, 2024, 4:30 PM EDT - Market closed
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $5.41 million as of May 7, 2024. Its market cap has decreased by -33.20% in one year.
Market Cap
5.41M
Enterprise Value
1.35M
1-Year Change
-33.20%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since December 2, 2010, Protagenic Therapeutics's market cap has decreased from $10.30M to $5.41M, a decrease of -47.47%. That is a compound annual growth rate of -4.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 6, 2024 | 5.50M | -3.51% |
May 3, 2024 | 5.70M | -6.56% |
May 2, 2024 | 6.10M | 5.17% |
May 1, 2024 | 5.80M | -4.92% |
Apr 30, 2024 | 6.10M | -3.17% |
Apr 29, 2024 | 6.30M | 3.28% |
Apr 26, 2024 | 6.10M | -12.86% |
Apr 25, 2024 | 7.00M | -4.11% |
Apr 24, 2024 | 7.30M | 4.29% |
Apr 23, 2024 | 7.00M | 27.27% |
Apr 22, 2024 | 5.50M | -3.51% |
Apr 19, 2024 | 5.70M | -6.56% |
Apr 18, 2024 | 6.10M | 1.67% |
Apr 17, 2024 | 6.00M | - |
Apr 16, 2024 | 6.00M | -3.23% |
Apr 15, 2024 | 6.20M | -3.13% |
Apr 12, 2024 | 6.40M | -12.33% |
Apr 11, 2024 | 7.30M | 1.39% |
Apr 10, 2024 | 7.20M | 4.35% |
Apr 9, 2024 | 6.90M | 1.47% |
Apr 8, 2024 | 6.80M | -4.23% |
Apr 5, 2024 | 7.10M | -2.74% |
Apr 4, 2024 | 7.30M | - |
Apr 3, 2024 | 7.30M | -2.67% |
Apr 2, 2024 | 7.50M | -2.60% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hoth Therapeutics | 5.92M |
Heart Test Laboratories | 5.82M |
Sintx Technologies | 5.75M |
Sonnet BioTherapeutics Holdings | 5.71M |
Soligenix | 5.70M |
Seelos Therapeutics | 5.64M |
Synaptogenix | 5.52M |
ThermoGenesis Holdings | 5.52M |